pasitheaclinics.com (KTTA) - סך הכנסות החברה

Pasithea Therapeutics (KTTA) utilizes a virtual drug development model, distributing synthesis and testing across overseas laboratories. The company's growth relies on AI-driven analysis of psychiatric disorders and the potential for M&A transactions. The company's sales dynamics demonstrate operational efficiency, where 0.00 serves as the final level marker. High hospital demand for ALS therapy confirms the viability of commercial planning within the neuropharmaceutical segment.
פילוחי מדדים מקיפים ואנליטיקה עבור pasitheaclinics.com (KTTA)

Pasithea Therapeutics focuses on bringing innovative ketamine-based neurotherapeutic drugs to market to combat depression and Alzheimer's disease. The company's gross sales volume dynamics reflect the effectiveness of commercializing these products, where daily revenue inflows demonstrate the business's ability to monetize developments and maintain market share, serving as a fundamental indicator of the business model's viability for the investor.